Unoprostone
From Wikipedia, the free encyclopedia
 |
|
|
Unoprostone
|
|
| Systematic (IUPAC) name | |
| (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-(3-oxodecyl) cyclopentyl]hept-5-enoic acid |
|
| Identifiers | |
| CAS number | 120373-24-2 (isopropyl) |
| ATC code | S01 |
| PubChem | |
| Chemical data | |
| Formula | C22H38O5 |
| Mol. mass | 382.534 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | Topical (eye drops) |
Unoprostone (INN) is a prostaglandin analogue. Its isopropyl ester, unoprostone isopropyl, is marketed under the trade name Rescula for the management of open-angle glaucoma and ocular hypertension.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
|
||||||||||||||||||||
